Foster City, CA, United States of America

Ryan McFadden

USPTO Granted Patents = 22 (Patent Applications = 7)

CIPO Patents = 1

EPO Patents = 15 (Patent Applications = 21)

Average Co-Inventor Count = 8.5

ph-index = 6

Forward Citations = 129(Granted Patents)

Company Filing History:

21 out of 919

Gilead Sciences, Inc.

patents

1 out of 4,547

California Institute of Technology

patents

Years Active: 2013-2024

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11878965 - Inhibitors of peptidylarginine deiminases (2024-01-23),

2. 11352329 - HIV protease inhibitors (2022-06-07),

3. 11179397 - Imidazopyrimidine derivatives (2021-11-23),

4. 11110091 - Modulators of toll-like receptors (2021-09-07),

5. 10800772 - Therapeutic compounds (2020-10-13),

6. 10774053 - HIV protease inhibitors (2020-09-15),

7. 10172860 - Modulators of toll-like receptors (2019-01-08),

8. 9879023 - Therapeutic compounds (2018-01-30),

9. 9573952 - Methods of preparing toll-like receptor modulators (2017-02-21),

10. 9464096 - Therapeutic compounds (2016-10-11),

11. 9452166 - Modulators of toll-like receptors (2016-09-27),

12. 9376392 - 2-(tert-butoxy)-2-(7-methylquinolin-6-yl) acetic acid derivatives for treating AIDS (2016-06-28),

13. 9284323 - Naphthalene acetic acid derivatives against HIV infection (2016-03-15),

14. 9127006 - Modulators of toll-like receptors (2015-09-08),

15. 9102614 - Naphth-2-ylacetic acid derivatives to treat AIDS (2015-08-11),

Title: **The Innovative Contributions of Ryan McFadden**

Introduction

Ryan McFadden, located in Foster City, California, is a prolific inventor with an impressive portfolio, holding 22 patents to his name. His work primarily focuses on biomedicine, particularly in developing therapeutic compounds that address critical health issues.

Latest Patents

Among his latest innovations, McFadden has developed inhibitors of peptidylarginine deiminases (PADs). This groundbreaking work involves novel compounds that show potential in treating diseases linked to PADs, specifically peptidylarginine deiminase type 4 (PAD4). Additionally, he has contributed to the field of HIV research with his latest patent on HIV protease inhibitors. This invention includes a compound designed to treat the proliferation of the HIV virus and aims to assist in managing AIDS symptoms effectively. His patents encompass processes for preparing these compounds and their application in pharmaceutical compositions.

Career Highlights

Throughout his career, McFadden has made significant contributions in prominent organizations. He has worked with Gilead Sciences, Inc., a leader in biotechnology, where his research has impacted therapeutic developments. Additionally, his involvement with the California Institute of Technology has positioned him at the forefront of innovation in scientific research and collaboration.

Collaborations

McFadden has worked alongside talented professionals in the field, including Hong Yang and Paul A. Roethle. These collaborations have fostered a dynamic exchange of ideas and expertise, contributing to the advancement of their collective research goals.

Conclusion

Ryan McFadden stands out as a significant figure in the field of biomedical invention. With a remarkable number of patents and groundbreaking research, his work continues to pave the way for innovative solutions to some of society's pressing health challenges. His dedication to research and collaboration exemplifies the spirit of innovation in the medical field.

This text is generated by artificial intelligence and may not be accurate.